Based on these data, we determined the prevalence of genetic polymorphisms of CDKN1A in a sample of 10 ependymomas, 16 medulloblastomas and 15 astrocytomas from the northwestern part of the State of São Paulo, compared with 161 control subjects. This evidence concerns the gene CDKN1A and ependymoma.